| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H19N |
| Molar mass | 237.346 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Etifelmine (INN; also known asgilutensin) is astimulant drug. It was used for the treatment ofhypotension (low blood pressure).[1]
The base-catalyzed reaction betweenbenzophenone (1) andbutyronitrile (2) gives 2-[hydroxy(diphenyl)methyl]butanenitrile (3).[2][3]Catalytic hydrogenation reduces the nitrile group to a primary amine giving 1,1-diphenyl-2-ethyl-3-aminopropanol (4). The tertiary hydroxyl group isdehydrated by treatment with anhydrous hydrogen chloride gas, completing the synthesis of etifelmine (5).

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |